A-769662 activated AMPK downstream targets involved in regulation of mitochondrial function. BMDMs were treated with direct AMPK activator A-769662 (100 μM) for 1 h before being stimulated with MSU crystals (0.2 mg/mL) for 6 or 18 h in RPMI containing 1% FBS. Western blot analysis was carried out to examine phosphorylation and expression of AMPKα, expression of SIRT1, PGC-1α, and TFAM, and expression of TXN1, TXN2, and TXNIP from 18-h treatment cells (A), and expression of LC3 and p62 from 6-h treatment cells (B). Data shown in A and B are representative of three individual experiments. (PDF 753 kb
Human astrocytes were pre-treated with 500 nM wortmannin (PI3K inhibitor) or 5 μM PD98059 (MEK1 inhi...
Figure S2. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S1. A) Von Frey filament, and grip strength analysis for BupOH and TTX at days 1 and 5. B) Vo...
Arhalofenate acid promoted autophagy flux. BMDMs were treated with arhalofenate acid (100 μM) for 1 ...
Supplemenal Fig. 1 Evaluation of adenylate kinase 4 (AK4) in A549 cells. (A) Western blotting evalua...
is Figure S2 showing treatment of MAPK inhibitors to AF cells with ROS. Real-time RT-PCR analysis of...
Figure S1. Experimental design timeline. a. Nociceptive behavioral tests of AICAR effect in mice. No...
BackgroundArhalofenate acid, the active acid form of arhalofenate, is a non-agonist peroxisome proli...
Figure S4. The effect of neutralizing TNF-α on MLO-Y4 cell inflammation induced by MSU crystal-stimu...
Figure S1. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S1. Immunoblotting data of main Fig. 1a-c were quantified using Image J software. Data were t...
Figure S3. Immunoblotting analysis of main Fig. 3 were quantified using Image J software. Data were ...
Supporting Information S1. Effects of Metformin on TNF-Îą, IL-6 and IL-10 production in RAW264.7. Su...
Figure S2. Effect of Zyflamend on the proliferation of a colorectal cancer cell line in vitro and th...
Figure S3. RAW264.7 macrophage expression of TNF-α and PGE2 in response to MSU crystals. RAW264.7 ma...
Human astrocytes were pre-treated with 500 nM wortmannin (PI3K inhibitor) or 5 μM PD98059 (MEK1 inhi...
Figure S2. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S1. A) Von Frey filament, and grip strength analysis for BupOH and TTX at days 1 and 5. B) Vo...
Arhalofenate acid promoted autophagy flux. BMDMs were treated with arhalofenate acid (100 μM) for 1 ...
Supplemenal Fig. 1 Evaluation of adenylate kinase 4 (AK4) in A549 cells. (A) Western blotting evalua...
is Figure S2 showing treatment of MAPK inhibitors to AF cells with ROS. Real-time RT-PCR analysis of...
Figure S1. Experimental design timeline. a. Nociceptive behavioral tests of AICAR effect in mice. No...
BackgroundArhalofenate acid, the active acid form of arhalofenate, is a non-agonist peroxisome proli...
Figure S4. The effect of neutralizing TNF-α on MLO-Y4 cell inflammation induced by MSU crystal-stimu...
Figure S1. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S1. Immunoblotting data of main Fig. 1a-c were quantified using Image J software. Data were t...
Figure S3. Immunoblotting analysis of main Fig. 3 were quantified using Image J software. Data were ...
Supporting Information S1. Effects of Metformin on TNF-Îą, IL-6 and IL-10 production in RAW264.7. Su...
Figure S2. Effect of Zyflamend on the proliferation of a colorectal cancer cell line in vitro and th...
Figure S3. RAW264.7 macrophage expression of TNF-α and PGE2 in response to MSU crystals. RAW264.7 ma...
Human astrocytes were pre-treated with 500 nM wortmannin (PI3K inhibitor) or 5 μM PD98059 (MEK1 inhi...
Figure S2. Selection of optimized concentrations of glimepiride and metformin for cell treatment. Ce...
Figure S1. A) Von Frey filament, and grip strength analysis for BupOH and TTX at days 1 and 5. B) Vo...